nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—PDE4A—Pentoxifylline—systemic scleroderma	0.422	0.512	CbGbCtD
Roflumilast—PDE4B—Pentoxifylline—systemic scleroderma	0.402	0.488	CbGbCtD
Roflumilast—Infection—Azathioprine—systemic scleroderma	0.000399	0.00227	CcSEcCtD
Roflumilast—Vertigo—Mycophenolic acid—systemic scleroderma	0.000398	0.00227	CcSEcCtD
Roflumilast—Fatigue—Captopril—systemic scleroderma	0.000397	0.00226	CcSEcCtD
Roflumilast—Myalgia—Leflunomide—systemic scleroderma	0.000395	0.00225	CcSEcCtD
Roflumilast—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.000395	0.00225	CcSEcCtD
Roflumilast—Anxiety—Leflunomide—systemic scleroderma	0.000394	0.00224	CcSEcCtD
Roflumilast—Constipation—Captopril—systemic scleroderma	0.000393	0.00224	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000393	0.00224	CcSEcCtD
Roflumilast—Tension—Lisinopril—systemic scleroderma	0.000392	0.00223	CcSEcCtD
Roflumilast—Palpitations—Mycophenolic acid—systemic scleroderma	0.000392	0.00223	CcSEcCtD
Roflumilast—Dysgeusia—Lisinopril—systemic scleroderma	0.000391	0.00223	CcSEcCtD
Roflumilast—Discomfort—Leflunomide—systemic scleroderma	0.000391	0.00222	CcSEcCtD
Roflumilast—Skin disorder—Azathioprine—systemic scleroderma	0.00039	0.00222	CcSEcCtD
Roflumilast—Nervousness—Lisinopril—systemic scleroderma	0.000388	0.00221	CcSEcCtD
Roflumilast—Back pain—Lisinopril—systemic scleroderma	0.000386	0.0022	CcSEcCtD
Roflumilast—Vomiting—Pentoxifylline—systemic scleroderma	0.000386	0.0022	CcSEcCtD
Roflumilast—Muscle spasms—Lisinopril—systemic scleroderma	0.000384	0.00219	CcSEcCtD
Roflumilast—Rash—Pentoxifylline—systemic scleroderma	0.000383	0.00218	CcSEcCtD
Roflumilast—Dermatitis—Pentoxifylline—systemic scleroderma	0.000382	0.00218	CcSEcCtD
Roflumilast—Headache—Pentoxifylline—systemic scleroderma	0.00038	0.00217	CcSEcCtD
Roflumilast—Feeling abnormal—Captopril—systemic scleroderma	0.000379	0.00216	CcSEcCtD
Roflumilast—Myalgia—Mycophenolic acid—systemic scleroderma	0.000377	0.00215	CcSEcCtD
Roflumilast—Infection—Leflunomide—systemic scleroderma	0.000377	0.00214	CcSEcCtD
Roflumilast—Gastrointestinal pain—Captopril—systemic scleroderma	0.000376	0.00214	CcSEcCtD
Roflumilast—Anxiety—Mycophenolic acid—systemic scleroderma	0.000376	0.00214	CcSEcCtD
Roflumilast—Asthenia—Mometasone—systemic scleroderma	0.000376	0.00214	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000375	0.00213	CcSEcCtD
Roflumilast—Tremor—Lisinopril—systemic scleroderma	0.000374	0.00213	CcSEcCtD
Roflumilast—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000373	0.00212	CcSEcCtD
Roflumilast—Discomfort—Mycophenolic acid—systemic scleroderma	0.000373	0.00212	CcSEcCtD
Roflumilast—Nervous system disorder—Leflunomide—systemic scleroderma	0.000372	0.00212	CcSEcCtD
Roflumilast—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00037	0.00211	CcSEcCtD
Roflumilast—Skin disorder—Leflunomide—systemic scleroderma	0.000368	0.0021	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000366	0.00208	CcSEcCtD
Roflumilast—Angioedema—Lisinopril—systemic scleroderma	0.000365	0.00208	CcSEcCtD
Roflumilast—Abdominal pain—Captopril—systemic scleroderma	0.000364	0.00207	CcSEcCtD
Roflumilast—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000362	0.00206	CcSEcCtD
Roflumilast—Nausea—Pentoxifylline—systemic scleroderma	0.000361	0.00205	CcSEcCtD
Roflumilast—Malaise—Lisinopril—systemic scleroderma	0.00036	0.00205	CcSEcCtD
Roflumilast—Infection—Mycophenolic acid—systemic scleroderma	0.000359	0.00205	CcSEcCtD
Roflumilast—Vertigo—Lisinopril—systemic scleroderma	0.000359	0.00204	CcSEcCtD
Roflumilast—Diarrhoea—Mometasone—systemic scleroderma	0.000358	0.00204	CcSEcCtD
Roflumilast—Renal failure acute—Methotrexate—systemic scleroderma	0.000356	0.00203	CcSEcCtD
Roflumilast—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000355	0.00202	CcSEcCtD
Roflumilast—Palpitations—Lisinopril—systemic scleroderma	0.000353	0.00201	CcSEcCtD
Roflumilast—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000352	0.002	CcSEcCtD
Roflumilast—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000351	0.002	CcSEcCtD
Roflumilast—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00035	0.00199	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000347	0.00197	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000345	0.00197	CcSEcCtD
Roflumilast—Tension—Mycophenolate mofetil—systemic scleroderma	0.000343	0.00195	CcSEcCtD
Roflumilast—Insomnia—Leflunomide—systemic scleroderma	0.000343	0.00195	CcSEcCtD
Roflumilast—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00195	CcSEcCtD
Roflumilast—Myalgia—Lisinopril—systemic scleroderma	0.00034	0.00193	CcSEcCtD
Roflumilast—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00034	0.00193	CcSEcCtD
Roflumilast—Anxiety—Lisinopril—systemic scleroderma	0.000339	0.00193	CcSEcCtD
Roflumilast—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000338	0.00193	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000337	0.00192	CcSEcCtD
Roflumilast—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000336	0.00191	CcSEcCtD
Roflumilast—Discomfort—Lisinopril—systemic scleroderma	0.000336	0.00191	CcSEcCtD
Roflumilast—Dyspepsia—Leflunomide—systemic scleroderma	0.000334	0.0019	CcSEcCtD
Roflumilast—Vomiting—Mometasone—systemic scleroderma	0.000333	0.0019	CcSEcCtD
Roflumilast—Feeling abnormal—Azathioprine—systemic scleroderma	0.000331	0.00188	CcSEcCtD
Roflumilast—Rash—Mometasone—systemic scleroderma	0.00033	0.00188	CcSEcCtD
Roflumilast—Asthenia—Captopril—systemic scleroderma	0.00033	0.00188	CcSEcCtD
Roflumilast—Dermatitis—Mometasone—systemic scleroderma	0.00033	0.00188	CcSEcCtD
Roflumilast—Decreased appetite—Leflunomide—systemic scleroderma	0.00033	0.00188	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00033	0.00188	CcSEcCtD
Roflumilast—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000328	0.00187	CcSEcCtD
Roflumilast—Headache—Mometasone—systemic scleroderma	0.000328	0.00187	CcSEcCtD
Roflumilast—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000328	0.00187	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000327	0.00186	CcSEcCtD
Roflumilast—Insomnia—Mycophenolic acid—systemic scleroderma	0.000327	0.00186	CcSEcCtD
Roflumilast—Fatigue—Leflunomide—systemic scleroderma	0.000327	0.00186	CcSEcCtD
Roflumilast—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000324	0.00185	CcSEcCtD
Roflumilast—Constipation—Leflunomide—systemic scleroderma	0.000324	0.00185	CcSEcCtD
Roflumilast—Infection—Lisinopril—systemic scleroderma	0.000324	0.00184	CcSEcCtD
Roflumilast—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00032	0.00182	CcSEcCtD
Roflumilast—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000318	0.00181	CcSEcCtD
Roflumilast—Abdominal pain—Azathioprine—systemic scleroderma	0.000317	0.00181	CcSEcCtD
Roflumilast—Skin disorder—Lisinopril—systemic scleroderma	0.000316	0.0018	CcSEcCtD
Roflumilast—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000315	0.0018	CcSEcCtD
Roflumilast—Diarrhoea—Captopril—systemic scleroderma	0.000315	0.00179	CcSEcCtD
Roflumilast—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000314	0.00179	CcSEcCtD
Roflumilast—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000314	0.00179	CcSEcCtD
Roflumilast—Feeling abnormal—Leflunomide—systemic scleroderma	0.000312	0.00178	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000312	0.00178	CcSEcCtD
Roflumilast—Fatigue—Mycophenolic acid—systemic scleroderma	0.000312	0.00178	CcSEcCtD
Roflumilast—Nausea—Mometasone—systemic scleroderma	0.000311	0.00177	CcSEcCtD
Roflumilast—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00031	0.00177	CcSEcCtD
Roflumilast—Constipation—Mycophenolic acid—systemic scleroderma	0.000309	0.00176	CcSEcCtD
Roflumilast—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000309	0.00176	CcSEcCtD
Roflumilast—Weight decreased—Prednisone—systemic scleroderma	0.000308	0.00175	CcSEcCtD
Roflumilast—Dizziness—Captopril—systemic scleroderma	0.000304	0.00173	CcSEcCtD
Roflumilast—Depression—Prednisone—systemic scleroderma	0.000302	0.00172	CcSEcCtD
Roflumilast—Urticaria—Leflunomide—systemic scleroderma	0.000301	0.00171	CcSEcCtD
Roflumilast—Abdominal pain—Leflunomide—systemic scleroderma	0.0003	0.00171	CcSEcCtD
Roflumilast—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000298	0.0017	CcSEcCtD
Roflumilast—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000298	0.0017	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000297	0.00169	CcSEcCtD
Roflumilast—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000297	0.00169	CcSEcCtD
Roflumilast—Hypersensitivity—Azathioprine—systemic scleroderma	0.000296	0.00168	CcSEcCtD
Roflumilast—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000296	0.00168	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000296	0.00168	CcSEcCtD
Roflumilast—Insomnia—Lisinopril—systemic scleroderma	0.000295	0.00168	CcSEcCtD
Roflumilast—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000294	0.00167	CcSEcCtD
Roflumilast—Vomiting—Captopril—systemic scleroderma	0.000292	0.00167	CcSEcCtD
Roflumilast—Rash—Captopril—systemic scleroderma	0.00029	0.00165	CcSEcCtD
Roflumilast—Dermatitis—Captopril—systemic scleroderma	0.00029	0.00165	CcSEcCtD
Roflumilast—Headache—Captopril—systemic scleroderma	0.000288	0.00164	CcSEcCtD
Roflumilast—Dyspepsia—Lisinopril—systemic scleroderma	0.000287	0.00163	CcSEcCtD
Roflumilast—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000286	0.00163	CcSEcCtD
Roflumilast—Infection—Mycophenolate mofetil—systemic scleroderma	0.000284	0.00161	CcSEcCtD
Roflumilast—Decreased appetite—Lisinopril—systemic scleroderma	0.000283	0.00161	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000281	0.0016	CcSEcCtD
Roflumilast—Fatigue—Lisinopril—systemic scleroderma	0.000281	0.0016	CcSEcCtD
Roflumilast—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00028	0.00159	CcSEcCtD
Roflumilast—Hypersensitivity—Leflunomide—systemic scleroderma	0.000279	0.00159	CcSEcCtD
Roflumilast—Constipation—Lisinopril—systemic scleroderma	0.000279	0.00159	CcSEcCtD
Roflumilast—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000277	0.00158	CcSEcCtD
Roflumilast—Diarrhoea—Azathioprine—systemic scleroderma	0.000275	0.00156	CcSEcCtD
Roflumilast—Nausea—Captopril—systemic scleroderma	0.000273	0.00156	CcSEcCtD
Roflumilast—Asthenia—Leflunomide—systemic scleroderma	0.000272	0.00155	CcSEcCtD
Roflumilast—Feeling abnormal—Lisinopril—systemic scleroderma	0.000268	0.00153	CcSEcCtD
Roflumilast—Connective tissue disorder—Prednisone—systemic scleroderma	0.000268	0.00152	CcSEcCtD
Roflumilast—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000266	0.00152	CcSEcCtD
Roflumilast—Dizziness—Azathioprine—systemic scleroderma	0.000265	0.00151	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00026	0.00148	CcSEcCtD
Roflumilast—Asthenia—Mycophenolic acid—systemic scleroderma	0.000259	0.00148	CcSEcCtD
Roflumilast—Diarrhoea—Leflunomide—systemic scleroderma	0.000259	0.00148	CcSEcCtD
Roflumilast—Urticaria—Lisinopril—systemic scleroderma	0.000259	0.00147	CcSEcCtD
Roflumilast—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000258	0.00147	CcSEcCtD
Roflumilast—Abdominal pain—Lisinopril—systemic scleroderma	0.000258	0.00147	CcSEcCtD
Roflumilast—Vomiting—Azathioprine—systemic scleroderma	0.000255	0.00145	CcSEcCtD
Roflumilast—Pneumonia—Methotrexate—systemic scleroderma	0.000255	0.00145	CcSEcCtD
Roflumilast—Infestation NOS—Methotrexate—systemic scleroderma	0.000254	0.00144	CcSEcCtD
Roflumilast—Infestation—Methotrexate—systemic scleroderma	0.000254	0.00144	CcSEcCtD
Roflumilast—Rash—Azathioprine—systemic scleroderma	0.000253	0.00144	CcSEcCtD
Roflumilast—Dermatitis—Azathioprine—systemic scleroderma	0.000253	0.00144	CcSEcCtD
Roflumilast—Depression—Methotrexate—systemic scleroderma	0.000253	0.00144	CcSEcCtD
Roflumilast—Headache—Azathioprine—systemic scleroderma	0.000251	0.00143	CcSEcCtD
Roflumilast—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000251	0.00143	CcSEcCtD
Roflumilast—Dizziness—Leflunomide—systemic scleroderma	0.000251	0.00143	CcSEcCtD
Roflumilast—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000248	0.00141	CcSEcCtD
Roflumilast—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000247	0.00141	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000246	0.0014	CcSEcCtD
Roflumilast—Immune system disorder—Prednisone—systemic scleroderma	0.000246	0.0014	CcSEcCtD
Roflumilast—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000244	0.00139	CcSEcCtD
Roflumilast—Vomiting—Leflunomide—systemic scleroderma	0.000241	0.00137	CcSEcCtD
Roflumilast—Hypersensitivity—Lisinopril—systemic scleroderma	0.00024	0.00137	CcSEcCtD
Roflumilast—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00024	0.00137	CcSEcCtD
Roflumilast—Dizziness—Mycophenolic acid—systemic scleroderma	0.000239	0.00136	CcSEcCtD
Roflumilast—Rash—Leflunomide—systemic scleroderma	0.000239	0.00136	CcSEcCtD
Roflumilast—Dermatitis—Leflunomide—systemic scleroderma	0.000239	0.00136	CcSEcCtD
Roflumilast—Mental disorder—Prednisone—systemic scleroderma	0.000239	0.00136	CcSEcCtD
Roflumilast—Nausea—Azathioprine—systemic scleroderma	0.000238	0.00136	CcSEcCtD
Roflumilast—Headache—Leflunomide—systemic scleroderma	0.000238	0.00135	CcSEcCtD
Roflumilast—Malnutrition—Prednisone—systemic scleroderma	0.000237	0.00135	CcSEcCtD
Roflumilast—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000235	0.00134	CcSEcCtD
Roflumilast—Asthenia—Lisinopril—systemic scleroderma	0.000234	0.00133	CcSEcCtD
Roflumilast—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000233	0.00133	CcSEcCtD
Roflumilast—Vomiting—Mycophenolic acid—systemic scleroderma	0.00023	0.00131	CcSEcCtD
Roflumilast—Rash—Mycophenolic acid—systemic scleroderma	0.000228	0.0013	CcSEcCtD
Roflumilast—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000228	0.0013	CcSEcCtD
Roflumilast—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000227	0.00129	CcSEcCtD
Roflumilast—Headache—Mycophenolic acid—systemic scleroderma	0.000227	0.00129	CcSEcCtD
Roflumilast—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000226	0.00128	CcSEcCtD
Roflumilast—Nausea—Leflunomide—systemic scleroderma	0.000225	0.00128	CcSEcCtD
Roflumilast—Diarrhoea—Lisinopril—systemic scleroderma	0.000223	0.00127	CcSEcCtD
Roflumilast—Ill-defined disorder—Prednisone—systemic scleroderma	0.00022	0.00125	CcSEcCtD
Roflumilast—Angioedema—Prednisone—systemic scleroderma	0.000217	0.00123	CcSEcCtD
Roflumilast—Dizziness—Lisinopril—systemic scleroderma	0.000215	0.00123	CcSEcCtD
Roflumilast—Nausea—Mycophenolic acid—systemic scleroderma	0.000215	0.00122	CcSEcCtD
Roflumilast—Malaise—Prednisone—systemic scleroderma	0.000214	0.00122	CcSEcCtD
Roflumilast—Vertigo—Prednisone—systemic scleroderma	0.000213	0.00121	CcSEcCtD
Roflumilast—Cardiac disorder—Methotrexate—systemic scleroderma	0.000211	0.0012	CcSEcCtD
Roflumilast—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00021	0.0012	CcSEcCtD
Roflumilast—Vomiting—Lisinopril—systemic scleroderma	0.000207	0.00118	CcSEcCtD
Roflumilast—Immune system disorder—Methotrexate—systemic scleroderma	0.000206	0.00117	CcSEcCtD
Roflumilast—Rash—Lisinopril—systemic scleroderma	0.000205	0.00117	CcSEcCtD
Roflumilast—Dermatitis—Lisinopril—systemic scleroderma	0.000205	0.00117	CcSEcCtD
Roflumilast—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000205	0.00117	CcSEcCtD
Roflumilast—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000205	0.00117	CcSEcCtD
Roflumilast—Headache—Lisinopril—systemic scleroderma	0.000204	0.00116	CcSEcCtD
Roflumilast—Myalgia—Prednisone—systemic scleroderma	0.000202	0.00115	CcSEcCtD
Roflumilast—Anxiety—Prednisone—systemic scleroderma	0.000201	0.00115	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.0002	0.00114	CcSEcCtD
Roflumilast—Discomfort—Prednisone—systemic scleroderma	0.000199	0.00114	CcSEcCtD
Roflumilast—Mental disorder—Methotrexate—systemic scleroderma	0.000199	0.00114	CcSEcCtD
Roflumilast—Malnutrition—Methotrexate—systemic scleroderma	0.000198	0.00113	CcSEcCtD
Roflumilast—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000195	0.00111	CcSEcCtD
Roflumilast—Dysgeusia—Methotrexate—systemic scleroderma	0.000194	0.0011	CcSEcCtD
Roflumilast—Nausea—Lisinopril—systemic scleroderma	0.000194	0.0011	CcSEcCtD
Roflumilast—Infection—Prednisone—systemic scleroderma	0.000192	0.00109	CcSEcCtD
Roflumilast—Back pain—Methotrexate—systemic scleroderma	0.000192	0.00109	CcSEcCtD
Roflumilast—Nervous system disorder—Prednisone—systemic scleroderma	0.00019	0.00108	CcSEcCtD
Roflumilast—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000189	0.00107	CcSEcCtD
Roflumilast—Skin disorder—Prednisone—systemic scleroderma	0.000188	0.00107	CcSEcCtD
Roflumilast—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000184	0.00105	CcSEcCtD
Roflumilast—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000181	0.00103	CcSEcCtD
Roflumilast—Rash—Mycophenolate mofetil—systemic scleroderma	0.00018	0.00102	CcSEcCtD
Roflumilast—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00018	0.00102	CcSEcCtD
Roflumilast—Headache—Mycophenolate mofetil—systemic scleroderma	0.000179	0.00102	CcSEcCtD
Roflumilast—Malaise—Methotrexate—systemic scleroderma	0.000179	0.00102	CcSEcCtD
Roflumilast—Vertigo—Methotrexate—systemic scleroderma	0.000178	0.00101	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000176	0.001	CcSEcCtD
Roflumilast—Insomnia—Prednisone—systemic scleroderma	0.000175	0.000996	CcSEcCtD
Roflumilast—Dyspepsia—Prednisone—systemic scleroderma	0.00017	0.00097	CcSEcCtD
Roflumilast—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000965	CcSEcCtD
Roflumilast—Myalgia—Methotrexate—systemic scleroderma	0.000169	0.00096	CcSEcCtD
Roflumilast—Decreased appetite—Prednisone—systemic scleroderma	0.000168	0.000958	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000168	0.000954	CcSEcCtD
Roflumilast—Fatigue—Prednisone—systemic scleroderma	0.000167	0.00095	CcSEcCtD
Roflumilast—Discomfort—Methotrexate—systemic scleroderma	0.000167	0.000949	CcSEcCtD
Roflumilast—Constipation—Prednisone—systemic scleroderma	0.000165	0.000942	CcSEcCtD
Roflumilast—Infection—Methotrexate—systemic scleroderma	0.000161	0.000915	CcSEcCtD
Roflumilast—Feeling abnormal—Prednisone—systemic scleroderma	0.000159	0.000908	CcSEcCtD
Roflumilast—Nervous system disorder—Methotrexate—systemic scleroderma	0.000159	0.000903	CcSEcCtD
Roflumilast—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000158	0.000901	CcSEcCtD
Roflumilast—Skin disorder—Methotrexate—systemic scleroderma	0.000157	0.000894	CcSEcCtD
Roflumilast—Urticaria—Prednisone—systemic scleroderma	0.000154	0.000875	CcSEcCtD
Roflumilast—Abdominal pain—Prednisone—systemic scleroderma	0.000153	0.000871	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000147	0.000839	CcSEcCtD
Roflumilast—Insomnia—Methotrexate—systemic scleroderma	0.000146	0.000833	CcSEcCtD
Roflumilast—Hypersensitivity—Prednisone—systemic scleroderma	0.000143	0.000812	CcSEcCtD
Roflumilast—Dyspepsia—Methotrexate—systemic scleroderma	0.000142	0.00081	CcSEcCtD
Roflumilast—Decreased appetite—Methotrexate—systemic scleroderma	0.000141	0.0008	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00014	0.000795	CcSEcCtD
Roflumilast—Fatigue—Methotrexate—systemic scleroderma	0.000139	0.000794	CcSEcCtD
Roflumilast—Asthenia—Prednisone—systemic scleroderma	0.000139	0.00079	CcSEcCtD
Roflumilast—Feeling abnormal—Methotrexate—systemic scleroderma	0.000133	0.000759	CcSEcCtD
Roflumilast—Diarrhoea—Prednisone—systemic scleroderma	0.000132	0.000754	CcSEcCtD
Roflumilast—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000132	0.000753	CcSEcCtD
Roflumilast—Urticaria—Methotrexate—systemic scleroderma	0.000128	0.000731	CcSEcCtD
Roflumilast—Dizziness—Prednisone—systemic scleroderma	0.000128	0.000728	CcSEcCtD
Roflumilast—Abdominal pain—Methotrexate—systemic scleroderma	0.000128	0.000728	CcSEcCtD
Roflumilast—Vomiting—Prednisone—systemic scleroderma	0.000123	0.0007	CcSEcCtD
Roflumilast—Rash—Prednisone—systemic scleroderma	0.000122	0.000695	CcSEcCtD
Roflumilast—Dermatitis—Prednisone—systemic scleroderma	0.000122	0.000694	CcSEcCtD
Roflumilast—Headache—Prednisone—systemic scleroderma	0.000121	0.00069	CcSEcCtD
Roflumilast—Hypersensitivity—Methotrexate—systemic scleroderma	0.000119	0.000678	CcSEcCtD
Roflumilast—Asthenia—Methotrexate—systemic scleroderma	0.000116	0.000661	CcSEcCtD
Roflumilast—Nausea—Prednisone—systemic scleroderma	0.000115	0.000654	CcSEcCtD
Roflumilast—Diarrhoea—Methotrexate—systemic scleroderma	0.000111	0.00063	CcSEcCtD
Roflumilast—Dizziness—Methotrexate—systemic scleroderma	0.000107	0.000609	CcSEcCtD
Roflumilast—Vomiting—Methotrexate—systemic scleroderma	0.000103	0.000585	CcSEcCtD
Roflumilast—Rash—Methotrexate—systemic scleroderma	0.000102	0.00058	CcSEcCtD
Roflumilast—Dermatitis—Methotrexate—systemic scleroderma	0.000102	0.00058	CcSEcCtD
Roflumilast—Headache—Methotrexate—systemic scleroderma	0.000101	0.000577	CcSEcCtD
Roflumilast—Nausea—Methotrexate—systemic scleroderma	9.6e-05	0.000547	CcSEcCtD
